<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Schoen Margarete</submitter><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-ECPF-GEOD-8772</full_dataset_link><project>EurocanPlatform</project><abstract>Interference with chemoresistance to enhance the efficacy of chemotherapeutics may be of great utility for cancer therapy. We have identified KINK-1 (Kinase Inhibitor of NF-κB-1), a highly selective small-molecule IKKβ inhibitor, as a potent suppressor of both constitutive and induced NF-κB activity in melanoma cells. While KINK-1 profoundly diminished various NF-κB-dependent gene products regulating proliferation, cytokine production or anti-apoptotic responses, the compound by itself showed little antiproliferative or pro-apoptotic activity on the cellular level. However, its combination with some cytostatics markedly enhanced their antitumoral activities in vitro, and doxorubicin-induced NF-κB activation, a mechanism implicated in chemoresistance, was abrogated by KINK-1. In addition, w</abstract><repository>biostudies-other</repository><experiment_type>transcription profiling by array</experiment_type><data_source>EurocanPlatform</data_source><pubmed_authors>Schoen Margarete</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcription profiling of human melanoma cells reveals KINK-1 a novel small-molecule inhibitor of IKK, enhances susceptibility of melanoma cells to antitumoral treatment</name><description>Interference with chemoresistance to enhance the efficacy of chemotherapeutics may be of great utility for cancer therapy. We have identified KINK-1 (Kinase Inhibitor of NF-κB-1), a highly selective small-molecule IKKβ inhibitor, as a potent suppressor of both constitutive and induced NF-κB activity in melanoma cells. While KINK-1 profoundly diminished various NF-κB-dependent gene products regulating proliferation, cytokine production or anti-apoptotic responses, the compound by itself showed little antiproliferative or pro-apoptotic activity on the cellular level. However, its combination with some cytostatics markedly enhanced their antitumoral activities in vitro, and doxorubicin-induced NF-κB activation, a mechanism implicated in chemoresistance, was abrogated by KINK-1. In addition, w</description><dates><release>2016-04-14T14:44:41Z</release><modification>2016-04-14T14:44:41Z</modification><creation>2016-04-14T14:44:41Z</creation></dates><accession>S-ECPF-GEOD-8772</accession><cross_references><GEO>GSE8772</GEO><ArrayExpress>E-GEOD-8772</ArrayExpress><EFO>EFO_0000756</EFO><EFO>EFO_0000322</EFO><ArrayExpress files>E-GEOD-8772</ArrayExpress files></cross_references></HashMap>